Clinical Profile of COVID-19 Infection in Postvaccination Individuals
This article describes the findings of an observational study carried out in India to examine the clinical profile of individuals detected to be COVID-19 positive post vaccination.
Cost-Benefit Analysis of Sacubitril/Valsartan in a Medicaid Population
The cost avoidance of heart failure–related hospitalizations and emergency department visits may outweigh the additional drug cost in Medicaid members adherent to sacubitril/valsartan.
Medicare Advantage Coverage Restrictions for the Costliest Physician-Administered Drugs
Four large Medicare Advantage insurers manage access to expensive physician-administered drugs with a combination of prior authorization, step therapy, and Part D formulary design.
Provider and Patient Insights Into the Cancer Care Journey
A survey was conducted to determine opportunities to aid primary care providers and patients in the difficult journey of an oncology patient.
Inpatient Opioid Receipt and Care Experiences for Vaginal Delivery
The objective of this study was to examine the relationship between inpatient opioid receipt and care experiences of women hospitalized for vaginal delivery.
Projected US Savings From Biosimilars, 2021-2025
Projected savings from biosimilars from 2021 to 2025 were $38.4 billion vs conditions as of quarter 4 of 2020 and were driven by new biosimilar entry. Savings were $124.5 billion under an upper-bound scenario.